Qing-yong Wang

HSP70 and modified HPV 16 E7 fusion gene without the addition of a signal peptide gene sequence as a candidate therapeutic tumor vaccine.

J. Zong, Changyuan Wang, Qing-yong Wang, 2013, Oncology reports.

Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.

Qing-yong Wang, Yu-fei Xu, Xue-mei Xu, 2007, Journal of medical microbiology.

Encapsidating artificial human papillomavirus‐16 mE7 protein in human papillomavirus‐6b L1/L2 virus like particles

Qing-yong Wang, Yu-fei Xu, Xue-mei Xu, 2007, Chinese medical journal.

Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects.

J. Zong, Qing-yong Wang, Qinglin Peng, 2009, Oncology reports.